Compare GNTA & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNTA | SST |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | Italy | United States |
| Employees | N/A | 300 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 27.4M |
| IPO Year | N/A | N/A |
| Metric | GNTA | SST |
|---|---|---|
| Price | $0.87 | $2.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 54.8K | 8.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $0.29 |
| 52 Week High | $10.00 | $11.30 |
| Indicator | GNTA | SST |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 21.52 |
| Support Level | $0.71 | $0.34 |
| Resistance Level | $1.70 | $4.61 |
| Average True Range (ATR) | 0.09 | 0.29 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 25.00 | 15.43 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.